|Year : 2018 | Volume
| Issue : 7 | Page : 352-359
Anti-epileptic effect of morin against experimental pentylenetetrazol-induced seizures via modulating brain monoamines and oxidative stress
Amit D Kandhare, Anwesha A Mukherjee, Subhash L Bodhankar
Department of Pharmacology, Poona College of Pharmacy, Bharati Vidyapeeth Deemed University, Erandwane, Paud Road, Pune-411 038, India
|Date of Submission||11-Apr-2018|
|Date of Decision||05-May-2018|
|Date of Acceptance||19-Jun-2018|
|Date of Web Publication||24-Jul-2018|
Amit D Kandhare
Department of Pharmacology, Poona College of Pharmacy, Bharati Vidyapeeth Deemed University, Erandwane, Paud Road, Pune-411 038
Source of Support: None, Conflict of Interest: None
Objective: To evaluate the protective effect of morin against pentylenetetrazol (PTZ)-induced tonic-clonic convulsions in mice. Methods: Swiss albino mice (18-22 g) was used to induce convulsions by intraperitoneal (i.p.) administration of PTZ (90 mg/kg). Mice were either pretreated with morin (10, 20 and 40 mg/kg) or vehicle (distilled water, 10 mg/kg) 45 min before PTZ administration. Various behavioral and biochemical parameters were assessed. Results: PTZ administration resulted in significant production (P<0.001) of tonic-clonic conclusion and mortality in mice. PTZ-induced increase in the duration of convulsion, onset of convulsion and mortality was inhibited significantly by morin (20 and 40 mg/kg) administration. The PTZ-induced decrease in brain GABA, dopamine and Na+K+ATPase levels and increase in xanthine oxidase activity were inhibited significantly by morin (20 and 40 mg/kg) treatment. The increased levels of malondialdehyde and nitric oxide level were significantly decreased by morin (20 and 40 mg/kg) treatment. Also, reduced levels of superoxide dismutase and glutathione were increased significantly by morin treatment. Conclusions: Results of the present study indicate that morin showed its anti-convulsant effect via modulating the levels of brain GABA, Na+K+ATPase, and oxido-nitrosative stress. Thus, morin can be a potential candidate for further clinical evaluations as an anti-epileptic agent.
Keywords: Brain GABA, Epilepsy, Morin, Nitric oxide, Pentylenetetrazol, Oxidative stress, Xanthine oxidase
|How to cite this article:|
Kandhare AD, Mukherjee AA, Bodhankar SL. Anti-epileptic effect of morin against experimental pentylenetetrazol-induced seizures via modulating brain monoamines and oxidative stress. Asian Pac J Trop Biomed 2018;8:352-9
|How to cite this URL:|
Kandhare AD, Mukherjee AA, Bodhankar SL. Anti-epileptic effect of morin against experimental pentylenetetrazol-induced seizures via modulating brain monoamines and oxidative stress. Asian Pac J Trop Biomed [serial online] 2018 [cited 2022 Jan 24];8:352-9. Available from: https://www.apjtb.org/text.asp?2018/8/7/352/237078
| 1. Introduction|| |
Epilepsy is a chronic disease of neurobiological system, affecting approximately 50/100 000 individual while 100/100 000 individual in developed and developing countries, respectively. It has been reported that epilepsy prevalence in India is about 1/18th of the world population which is about 5.5-7.9/1 000 individual. The children below 7 years-of-age and person of above 55 years have the higher epilepsy incidence.
Research carried out over past decades indicated that there are various mechanisms responsible for triggering neuronal injury,,. This mechanism includes an imbalance between the neurotransmitter system such as glutamate-GABA (gamma-Aminobutyric acid) or impairment in voltage- and receptor-gated ion channels which plays a decisive role in the neuronal cell death. This resulted in various disorders of neurobiological system such as epilepsy, Alzheimer’s disease, parkinsonism and ischemia,. The increase in the consequence of epileptic seizures led to the development of many antiepileptic drugs for ameliorating the neuronal damage.
Currently available synthetic antiepileptic drugs such as oxcarbazepine, vigabatrin, topiramate, zonisamide, levetiracetam, etc. provide the symptomatic relief in epileptic seizures in the fraction of the patients. Moreover, a combination of antiepileptic drugs is associated with side effects and may increase the complications in the clinical management of epilepsy. Additionally, the treatments for epilepsy have not progressed substantially in recent years. Hence, alternative treatment strategies are required.
Numerous evidence suggested that oxidative stress is most evaluated mechanisms of epilepsy along with other. Increased oxidative stress is associated with elevated levels of Reactive Oxygen Species (ROS). This ROS leads to damage to the neurons which may have the minimal regenerative capacity,,,. Hence, drugs that alleviate or terminate ROS damage in brain serve to slow down or reduce aggravations of the disease condition. Research carried out over past decade investigated the application of traditional medicines for the management of epilepsy,. Many herbal isolated moieties from plant origin have shown promising efficacy in clinical and preclinical settings for the treatment of epilepsy,. These facts and figures support the research for the selection of moieties from the plant origin for epilepsy treatment.
Morin [2-(2,4-dihydroxyphenyl)-3, 5, 7-trihydroxy-4H-1-benzopyran-4-one], a flavonoid from plant origin, has potent antioxidant property. Morin possesses a plethora of treatment effects such as anti-inflammatory, anti-asthmatic, cardioprotective, anti-cancer, renoprotective, anti-allergic, antihypertensive, antiulcer,,,,,,,,,,. Pentylenetetrazol (PTZ)-induced seizure in animals is widely used and well established experimental model for determination of efficacy of various molecules in generalized tonic-clonic convulsions,,,. The researcher showed that PTZ induces convulsions by blocking the picrotoxin-sensitive site of the GABAA receptor. It has also been reported that PTZ induces alterations in membrane phospholipid metabolism which in turn results in the release of free radicals via elevated oxidative stress. Various chemical moieties from the class of flavonoids such as fisetin, quercetin, rutin, baicalein, scutellarein, wogonin, and baicalein have been reported to possess the anticonvulsive potential which was mediated by the GABAergic neuron,. To the best of our knowledge, the antiepileptic efficacy of morin has not been evaluated yet. Hence, present investigation aimed to assess the anti-epileptic efficacy of morin in PTZ-induced tonic-clonic convulsions in experimental animals.
| 2. Materials and methods|| |
2.1. Drugs and chemicals
Morin and PTZ (Sigma Chemical Co., St Louis, MO, USA), 1, 1’, 3, 3’ tetraethoxypropane, crystalline beef liver catalase, 5,5’-dithiobis (2-nitrobenzoic acid) (S.D. Fine Chemicals, Mumbai, India), sulphanilamides, naphthylamine diamine HCl, and phosphoric acid (Loba Chemie Pvt. Ltd., Mumbai, India) were procured from respective manufacturer. Diazepam was obtained from Symed Pharmaceuticals Pvt. Ltd., Hyderabad, India.
2.2. Experimental animals
Adult male Swiss albino mice (18-22 g) were obtained from the National Institute of Biosciences, Pune (India) and maintained at (24 ± 1) °C with a relative humidity of 45%-55% and 12:12 h dark/light cycle. The animals had free access to standard pellet chow (Pranav Agro-industries Ltd., Sangli, India) and water throughout the experimental protocol. All experiments were carried out between 09:00 and 17:00. The experiment was performed in accordance with the guidelines of Committee for Control and Supervision of Experimentation on Animals, Government of India on animal experimentation. Animals were brought to the testing laboratory 1 h before the experimentation for adaptation purpose. All the experimental protocols used in this study were approved by Institutional Animal Ethical Committee (CPCSEA/77/2010). The experimentation was conducted in noise free area.
2.3. Experimental design
PTZ-induced convulsion was induced according to previously reported protocol,,. Mice were randomly divided into following groups (n=6) as follows:
Group I: Normal (N): Mice were treated with distilled water [10 mg/kg, intraperitoneally (i.p.)] and received normal saline (10 mg/kg, i.p.) 45 min after administration of distilled water.
Group II : Pentylenetetrazol control (PTZ control): Mice were treated with distilled water (10 mg/kg, i.p.) and received PTZ (90 mg/kg, i.p.) 45 min after administration of distilled water.
Group III: Morin (10 mg/kg) [M (10)]: Mice were treated with morin (10 mg/kg, i.p.) and received PTZ (90 mg/kg, i.p.) 45 min after administration of morin.
Group IV: Morin (20 mg/kg) [M (20)]: Mice were treated with morin (20 mg/kg, i.p.) and received PTZ (90 mg/kg, i.p.) 45 min after administration of morin.
Group V: Morin (40 mg/kg) [M (40)]: Mice were treated with morin (40 mg/kg, i.p.) and received PTZ (90 mg/kg, i.p.) 45 min after administration of morin.
Group VI: Diazepam (5 mg/kg) [DZP (5)]: Mice were treated daily with diazepam (5 mg/kg, i.p.) and received PTZ (90 mg/kg, i.p.) 30 min after administration of diazepam.
The dose selection for morin (10, 20 and 40 mg/kg) was based on a previous study. The symptoms in mice such onset and duration of clonic-tonic convulsion, as well as incidence (number of mice showing convulsions) and mortality, were observed for next 30 min immediately after PTZ administration.
2.4. Locomotor activity
The percentage reduction in locomotor activity after administration of morin was determined according to previously reported methods by using actophotometer (National Scientific Apparatus Works, India),,.
2.5. Biochemical evaluation
2.5.1. Brain GABA and dopamine (DA) estimation
As soon as the onset of convulsions occured, mice were sacrificed, and brain was isolated immediately. Previously reported methods were used for evaluation of brain GABA and DA.
2.5.2. Brain oxido-nitrosative stress, Na+K+ATPase and xanthine oxidase (XO) estimation
The contents of superoxide dismutase (SOD), glutathione (GSH), malondialdehyde (MDA), nitric oxide (NO content), Na+K+ATPase and XO were estimated in the brain according to previously reported methods,,,,,,,.
2.6. Statistical analysis
Data were expressed as mean ± standard error mean (SEM). The data were analyzed using one-way analysis of variance (ANOVA), Dunnett’s multiple range test was applied for post hoc analysis. Data of ‘incidence of convulsion’ was analyzed by the Chi-square test. Data of ‘mortality’ was analyzed by Fisher’s exact test. The statistical analysis was performed using GraphPad Prism 5.0 (GraphPad, San Diego, USA). The P<0.05 was considered as statistically significant.
| 3. Results|| |
3.1. Effects of morin on duration and onset of tonic-clonic convulsion
Administration of PTZ caused hind-limb and tonic-clonic seizure whereas morin (20 and 40 mg/kg) pretreated significantly (P<0.05 and P<0.001, respectively) delayed the onset of convulsion when compared with PTZ control mice. When compared with PTZ control mice, administration of morin (20 and 40 mg/kg) significantly (P<0.001) decreased tonic-clonic convulsion duration. Diazepam (5 mg/kg) treated mice also showed significant (P<0.001) attenuation in the PTZ-induced onset of convulsion and duration of tonic-clonic seizure as compared to PTZ control mice [Figure 1].
|Figure 1: Effects of morin and diazepam on PTZ-induced duration and the onset of tonic-clonic convulsion in mice.|
Data are expressed as mean ± SEM, n = 6 in each group. The number in parenthesis for the treatment group indicates dose in mg/kg. Data are analyzed by one-way ANOVA followed by Dunnett’s test. *P<0.05, and ***P<0.001 as compared to PTZ control mice.
Click here to view
3.2. Effects of morin on mortality
Administration of PTZ caused mortality in mice whereas mice which were pretreated with morin (20 and 40 mg/kg) significantly (P<0.01 and P<0.001, respectively) and dose-dependently decreased PTZ-induced mortality in mice. Incidence of convulsion was also significantly decreased (P<0.01 and P<0.001 respectively) by morin (20 and 40 mg/kg). Diazepam (5 mg/kg) treated mice also showed significant (P<0.001) reduction in mortality as well as convulsion incidence as compared to PTZ control mice [Table 1].
|Table 1: Effects of morin and diazepam on PTZ-induced convulsions and locomotor activity in mice.|
Click here to view
3.3. Effects of morin on locomotor activity
The locomotor activity did not differ significantly in the diazepam (5 mg/kg), morin (10, 20 and 40 mg/kg) treated as well as normal mice before treatment. There was significant (P<0.05 and P<0.001) and dose-dependent decrease in locomotor activity that has been observed in morin (10, 20 and 40 mg/kg) post-treatment when compared with normal mice. Diazepam (5 mg/kg) treated mice also significantly (P<0.001) reduced locomotor activity when compared with normal mice [Table 1].
3.4. Effect of morin on brain GABA and DA level
When compared with normal mice, PTZ control group significantly (P<0.001) reduced brain GABA and DA levels. The brain GABA level was significantly (P<0.05, and P<0.001) and dose-dependently increased by morin (20 and 40 mg/kg) treatment as compared to PTZ control group. It also showed a significant increase (P<0.05) in brain DA level when compared with PTZ control mice. Moreover, compared with PTZ control animal group, a significant (P<0.001 and P<0.01) increase in brain GABA and DA level was observed in diazepam (5 mg/kg) treated animal group [Figure 2].
|Figure 2: Effects of morin and diazepam on PTZ-induced alterations in brain GABA (A), DA (B), Na+K+ATPase (C) and XO activity (D) in mice.|
Data are expressed as mean ± SEM, n = 6 in each group. The number in parenthesis for the treatment group indicates dose in mg/kg. Data are analyzed by one-way ANOVA followed by Dunnett’s test. ###P<0.001 as compared to normal mice. *P<0.05, **P<0.01, and ***P<0.001 as compared to PTZ control mice.
Click here to view
3.5. Effect of morin on Na+K+ATPase activity
A significant decrease (P<0.001) in Na+K+ATPase activity was found in PTZ control animal when compared with normal mice. Morin (20 and 40 mg/kg) treated mice significantly (P<0.01 and P<0.001) and dose-dependently increased Na+K+ATPase activity when compared with PTZ control mice. Treatment with diazepam (5 mg/kg) also significantly (P<0.01) increased Na+K+ATPase activity when compared with PTZ control mice [Figure 2].
3.6. Effect of morin on XO activity
PTZ administration resulted in a significant increase (P<0.001) in XO activity in PTZ control mice. Mice pretreated with morin (20 and 40 mg/kg) showed significant (P<0.05 and P<0.01) and dose-dependent decrease in XO activity when compared with PTZ control mice. Diazepam (5 mg/kg) treated mice significantly (P<0.001) reduced the PTZ-induced increase in XO activity as compared to PTZ control mice [Figure 2].
3.7. Effect of morin on oxido-nitrosative stress
The SOD and GSH activities were significantly (P<0.001) decreased, and MDA and NO activities were significantly (P<0.001) increased in PTZ control animal as compared to normal mice. A significant (P<0.05, P<0.001 and P<0.001) and dose-dependent increase in SOD level was observed in morin (10, 20 and 40 mg/ kg) treated mice when compared to PTZ control mice group, respectively. The GSH activity was significantly (P<0.01 and P<0.001) and dose-dependently increased in morin (10, 20 and 40 mg/kg) treated mice as compared to PTZ control mice. There was significant (P<0.01 and P<0.001) and dose-dependent reduction in MDA level that has been observed in morin (20 and 40 mg/kg) when compared to PTZ control mice. Besides, morin (20 and 40 mg/kg) significantly (P<0.05) decreased PTZ-induced increased NO level as compared to PTZ control mice. Diazepam (5 mg/kg) treated mice also showed significant (P<0.01 and P<0.001) improvement in PTZ-induced alterations in oxido-nitrosative stress when compared with PTZ control mice [Table 2].
|Table 2: Effects of morin and diazepam on PTZ-induced alteration in oxido-nitrosative stress in mice.|
Click here to view
| 4. Discussion|| |
Epilepsy is a chronic neurobiological disease mainly characterized by repeated convulsions due to excessive activation of cerebral neurons. An array of neurotransmitter plays an essential role in the generation and maintenance of convulsions. Thus, reduction in duration, as well as the onset of tonic and clonic seizures by modulating these neurotransmitters, is vital parameter to judge drug efficacy in-vivo. GABA serves as a vital neurotransmitter in a number of neurodegenerative disorders including seizure mainly. Many researchers also reported the role of DA in the pathogenesis of epilepsy besides GABA. Thus, DA agonists such as bromocriptine, lisuride, pergolide, and apomorphine are also potential targets of epilepsy,. Present investigation evaluated the potential of morin against PTZ-induced convulsions by assessing various behavioral and biochemical parameters. Administration of morin significantly attenuated the PTZ-induced alterations in duration and onset of a tonic-clonic seizure, mortality, locomotor activity, brain GABA and DA levels, Na+K+ATPase and XO activity and oxido-nitrosative stress in mice.
PTZ is a GABAA receptor antagonist which blocks GABA-mediated Cl- influx. Deficiency in GABAergic transmission (through GABAA ionotropic receptor) leads to neuronal Cl- deficiency associated with abnormal neuronal discharges of hyperexcitable nature, which otherwise acts through GABAA ionotropic receptor,. This tends to shift the excitatory NMDA (N-methyl-D-aspartate receptor) and AMPA (α -amino-3-hydroxy-5-methylisoxazole-4-propionic acid) neurotransmitter pathways on alone discharge state and results in activation of excitable tonic and clonic phases of seizures. It has been well documented that the drugs that activate GABAergic transmissions or influence its physiology influence the induction and onset of convulsions. Furthermore, DA receptor pathway plays a significant role in the determination of the epileptic pathophysiology. Activation of D2 receptors resulted in increased brain DA levels that in turn caused anti-epileptic potentials. In the present study, pre-treatment with morin showed a significant reduction in the duration and onset of tonic-clonic convulsions which may be due to increase in the activity of GABA and DA levels. These findings suggest that morin may have GABA and DA receptor activation property which contributes to its anti-epileptic potential.
The researcher has reported that ionic control is one of the prime importance in epilepsy. It is an interesting fact that when extracellular K+ concentration increases, i.e., the transmembrane potential changes from -60 mV, the terminal and neuronal depolarization leading to abnormal neurotransmitter release and action potential discharges, respectively. An abnormality in the electrochemical gradients reflects a Na+K+ATPase pumps abnormality which is present in the plasma membrane. Blockade of this pump is associated with aggravations of epilepsy. In the current investigation, intraperitoneal PTZ administration resulted in decreased activity of Na+K+ATPase significantly, which is in accordance with the findings of previous researchers. Morin treatment enhances the activity of Na+K+ATPase which may lead to decrease in seizures.
It has been suggested that elevated levels of XO associated with increased ROS generation during the epileptic seizures,,. Activation of XO resulted in neuronal cell apoptosis by degradation of intracellular adenine nucleotides. Studies have reported that administration of antioxidants plays a protective role during convulsion,. The antioxidants have potential to quench the ROS such as superoxide anion, hydroxyl, and peroxyl radicals thus protected cellular components,,,. Administration of morin which is a potent antioxidant showed significant inhibition of XO which may provide the credence to its antiepileptic potential.
Results of previous studies have suggested that there is a correlation between elevated oxidative stress and epilepsy,. The intracellular antioxidant enzymes include dismutase such as SOD and catalases which are a potent scavenger of toxic O2. that converted to non-toxic H2O2,,,,. It has been reported that decrease in SOD level manifests neuronal ROS injury,,. Thus, increase in SOD level by means of administration of exogenous antioxidant substance may facilitate termination of free radical activity associated with neuronal damages,,. Reduced GSH is another important cellular defense antioxidant,,. Studies reported that administration of PTZ intraperitoneally caused decreased levels of GSH. However, administration of morin significantly elevated these cellular antioxidant levels. The findings of the present study are corroborated with the results of previous researchers where treatment with morin significantly increased the SOD and GSH levels,,.
Increased MDA level is an essential hallmark for the increased lipid peroxidation in the neuronal tissue. MDA is associated with neuronal damage by targeting polyunsaturated fatty acids (PUFAs),,. In addition to MDA, increased level of NO plays a decisive role in oxidative damage,,,. NO interacts with superoxide to generate the peroxynitrite which leads to neural damage. PTZ induces NO production in the hippocampus of the brain, maybe by increasing glutamate release and subsequently reducing GABA levels in brain. Thus, inhibition of NO may act in line with the GABA facilitation. Morin treatment showed significant inhibition in PTZ-induced increase in MDA and NO levels which in turn may increase GABA levels to exert its anticonvulsant potential.
In conclusion, the findings of the present study demonstrate that morin shows its anti-convulsant effect via modulating the levels of brain GABA, Na+K+ATPase, and oxido-nitrosative stress. Thus, morin can be a potential candidate for further clinical evaluations as an anti-epileptic agent.
Conflict of interest statement
The authors declare there is no conflicts of interest.
The authors would like to acknowledge Dr. S. S. Kadam, Chancellor, and Dr. K. R. Mahadik, Principal, Poona College of Pharmacy, Bharati Vidyapeeth Deemed University, Pune for providing necessary facilities to carry out the study.
| References|| |
Mehndiratta MM, Wadhai SA. International Epilepsy Day - A day notified for global public education & awareness. Indian J Med Res
Nag D. Gender and epilepsy: A clinician’s experience. Neurol India
Gosavi TP, Kandhare AD, Ghosh P, Bodhankar SL. Anticonvulsant activity of Argentum metallicum
, a homeopathic preparation. Der Pharmacia Lettre
Raygude KS, Kandhare AD, Ghosh P, Bodhankar SL. Anticonvulsant effect of fisetin by modulation of endogenous biomarkers. Biomed Prev Nutr
Raygude KS, Kandhare AD, Ghosh P, Ghule AE, Bodhankar SL. Evaluation of ameliorative effect of quercetin in experimental model of alcoholic neuropathy in rats. Inflammopharmacol
Martin ED, Araque A, Buno W. Synaptic regulation of the slow Ca2+
current in hippocampal CA1 pyramidal neurons: Implication in epileptogenesis. J Neurophysiol
Gosavi T, Ghosh P, Kandhare A, Bodhankar S. Unwrapping homeopathic principles in the wake of research: Serendipity, placebo or true therapeutic milestones. Pharmacologyonline
Pitkanen A. Efficacy of current antiepileptics to prevent neurodegeneration in epilepsy models. Epilepsy Res
Olesen AE, Andresen T, Staahl C, Drewes AM. Human experimental pain models for assessing the therapeutic efficacy of analgesic drugs. Pharmacol Rev
Saxena VS, Nadkarni VV. Nonpharmacological treatment of epilepsy. Ann Indian Acad Neurol
Adil M, Visnagri A, Kumar VS, Kandhare AD, Ghosh P, Bodhankar S. Protective effect of naringin on sodium arsenite induced testicular toxicity via modulation of biochemical perturbations in experimental rats. Pharmacologia
Honmore VS, Kandhare AD, Kadam PP, Khedkar VM, Sarkar D, Bodhankar SL, et al. Isolates of Alpinia officinarum
Hance as COX-2 inhibitors: Evidence from anti-inflammatory, antioxidant and molecular docking studies. Int Immunopharmacol
Kandhare AD, Mukherjee AA, Ghosh P, Bodhankar SL. Efficacy of antioxidant in idiopathic pulmonary fibrosis: A systematic review and meta-analysis. EXCLI J
Goldenberg MM. Overview of drugs used for epilepsy and seizures: Etiology, diagnosis, and treatment. Pharm Ther
Ekstein D, Schachter SC. Natural products in epilepsy-the present situation and perspectives for the future. Pharmaceuticals (Basel)
Kapoor R, Kakkar P. Protective role of morin, a flavonoid, against high glucose induced oxidative stress mediated apoptosis in primary rat hepatocytes. PloS One
Gupta SC, Phromnoi K, Aggarwal BB. Morin inhibits STAT3 tyrosine 705 phosphorylation in tumor cells through activation of protein tyrosine phosphatase SHP1. Biochem Pharmacol
Wei Z, He X, Kou J, Wang J, Chen L, Yao M, et al. Renoprotective mechanisms of morin in cisplatin-induced kidney injury. Int Immunopharmacol
Middleton E, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol Rev
Kim JW, Lee JH, Hwang BY, Mun SH, Ko NY, Kim DK, et al. Morin inhibits Fyn kinase in mast cells and IgE-mediated type I hypersensitivity response in vivo. Biochem Pharmacol
Prahalathan P, Kumar S, Raja B. Morin attenuates blood pressure and oxidative stress in deoxycorticosterone acetate-salt hypertensive rats: A biochemical and histopathological evaluation. Metabolism
Kandhare AD, Bodhankar SL. Effect of morin in bleomycin-induced pulmonary fibrosis in rats: Critical role of inflammatory, fibrotic and apoptotic biomarkers. World Allergy Organ J
2017; 10 Suppl 1
Kandhare AD, Ghosh P, Bodhankar SL. Morin attenuates airway hyperresponsiveness of allergic asthma via down regulation of immune-inflammatory biomarkers. Proceedings of the 15th International Congress of Immunology
. Milan, Italy; 2013.
Nandhakumar R, Salini K, Niranjali Devaraj S. Morin augments anticarcinogenic and antiproliferative efficacy against 7,12-dimethylbenz(a)-anthracene induced experimental mammary carcinogenesis. Mol Cell Biochem
Galvez J, Coelho G, Crespo ME, Cruz T, Rodríguez-Cabezas ME, Concha A, et al. Intestinal anti-inflammatory activity of morin on chronic experimental colitis in the rat. Aliment Pharmacol Ther
Patil A, Guru A, Mukherjee A, Sengupta A, Sarkar S, Parmar HM, et al. Elucidation of gastro-protective activity of morin in pylorus ligation induced gastric ulcer via modulation of oxidative stress. Der Pharmacia Lettre
Sarkar A, Sengupta A, Mukherjee A, Guru A, Patil A, Kandhare AD, et al. Antiulcer potential of morin in acetic acid-induced gastric ulcer via modulation of endogenous biomarkers in laboratory animals. Pharmacologia
Kandhare A, Raygude K, Ghosh P, Gosavi T, Bodhankar S. Patentability of animal models: India and the Globe. Int J Pharm Biol Arc
Patil MVK, Kandhare AD, Ghosh P, Bhise SD. Determination of role of GABA and nitric oxide in anticonvulsant activity of Fragaria vesca
L.ethanolic extract in chemically induced epilepsy in laboratory animals. Orient Pharm Exp Med
Wasowski C, Marder M. Flavonoids as GABAA receptor ligands: The whole story? J Exp Pharmacol
Ramalingam R, Nath AR, Madhavi BB, Nagulu M, Balasubramaniam A. Free radical scavenging and antiepileptic activity of Leucas lanata. J Pharm Res
Diniz TC, Silva JC, de Lima-Saraiva SR, Ribeiro FP, Pacheco AG, de Freitas RM, et al. The role of flavonoids on oxidative stress in epilepsy. Oxid Med Cell Longev
Nabeshima T, Tohyama K, Murase K, Ishihara S, Kameyama T, Yamasaki T, et al. Effects of DM-9384, a cyclic derivative of GABA, on amnesia and decreases in GABAA and muscarinic receptors induced by cycloheximide. J Pharmacol Exp Ther
Fleming RM, Clark WG. Single extraction method for the simultaneous fluorometric determination of serotonin, dopamine, and norepinephrine in brain. Anal Chem
Kandhare AD, Ghosh P, Ghule AE, Bodhankar SL. Elucidation of molecular mechanism involved in neuroprotective effect of Coenzyme Q10 in alcohol-induced neuropathic pain. Fundam Clin Pharmacol
Visnagri A, Kandhare AD, Kumar VS, Rajmane AR, Mohammad A, Ghosh P, et al. Elucidation of ameliorative effect of Co-enzyme Q10 in streptozotocin-induced diabetic neuropathic perturbation by modulation of electrophysiological, biochemical and behavioral markers. Biomed Aging Pathol
Visnagri A, Adil M, Kandhare AD, Bodhankar SL. Effect of naringin on hemodynamic changes and left ventricular function in renal artery occluded renovascular hypertension in rats. J Pharm Bioallied Sci
Kandhare AD, Bodhankar SL, Mohan V, Thakurdesai PA. Prophylactic efficacy and possible mechanisms of oligosaccharides based standardized fenugreek seed extract on high-fat diet-induced insulin resistance in C57BL/6 mice. J App Pharm Sci
Kandhare AD, Bodhankar SL, Mohan V, Thakurdesai PA. Acute and repeated doses (28 days) oral toxicity study of glycosides based standardized fenugreek seed extract in laboratory mice. Regul Toxicol Pharmacol
Kumar VS, Rajmane AR, Adil M, Kandhare AD, Ghosh P, Bodhankar SL. Naringin ameliorates acetic acid induced colitis through modulation of endogenous oxido-nitrosative balance and DNA damage in rats. J Biomed Res
Patil MVK, Kandhare AD, Bhise SD. Anti-arthritic and anti-inflammatory activity of Xanthium srtumarium
L. ethanolic extract in Freund’s complete adjuvant induced arthritis. Biomed Aging Pathol
Patil MVK, Kandhare AD, Bhise SD. Effect of aqueous extract of Cucumis sativus
Linn. fruit in ulcerative colitis in laboratory animals. Asian Pac J Trop Biomed
Treiman DM. GABAergic mechanisms in epilepsy. Epilepsia
2001; 42 Suppl 3:
Starr MS. The role of dopamine in epilepsy. Synapse
Choi J, Yoo Y, Park H. Inhibitory effects of the Korean red ginseng extract on the content of neurotransmitter-related components of the mouse brain in convulsion-induced model. Nat Prod Sci
Scharfman HE. The neurobiology of epilepsy. Curr Neurol Neurosci Rep
Souza MA, Oliveira MS, Furian AF, Rambo LM, Ribeiro LR, Lima FD, et al. Swimming training prevents pentylenetetrazol-induced inhibition of Na+
-ATPase activity, seizures, and oxidative stress. Epilepsia
Kandhare AD, Mukherjee A, Bodhankar SL. Antioxidant for treatment of diabetic nephropathy: A systematic review and meta-analysis. Chem Biol Interact
Adil M, Kandhare AD, Dalvi G, Ghosh P, Venkata S, Raygude KS, et al. Ameliorative effect of berberine against gentamicin-induced nephrotoxicity in rats via attenuation of oxidative stress, inflammation, apoptosis and mitochondrial dysfunction. Ren Fail
Adil M, Mansoori MN, Singh D, Kandhare AD, Sharma M. Pioglitazone-induced bone loss in diabetic rats and its amelioration by berberine: A portrait of molecular crosstalk. Biomed Pharmacother
Mukherjee A, Kandhare AD, Bodhankar SL. Effect of chrysin on gentamicin-induced nephrotoxicity in laboratory animals. Pharmacologia
Adil M, Kandhare AD, Ghosh P, Bodhankar SL. Sodium arsenite-induced myocardial bruise in rats: Ameliorative effect of naringin via TGF- β /Smad and Nrf/HO pathways. Chem Biol Interact
Ghule AE, Kandhare AD, Jadhav SS, Zanwar AA, Bodhankar SL. Omega-3-fatty acid adds to the protective effect of flax lignan concentrate in pressure overload-induced myocardial hypertrophy in rats via modulation of oxidative stress and apoptosis. Int Immunopharmacol
Kandhare AD, Kumar VS, Adil M, Rajmane AR, Ghosh P, Bodhankar SL. Investigation of gastro protective activity of Xanthium strumarium
L. by modulation of cellular and biochemical marker. Orient Pharm Exp Med
Kandhare AD, Mukherjee A. Efficacy of antioxidant supplements on prevention and amelioration of cisplatin-induced nephrotoxicity: A systematic review and meta-analysis of randomized controlled trials. Value in Health
Mukherjee AA, Kandhare AD, Rojatkar SR, Bodhankar SL. Ameliorative effects of Artemisia pallens
in a murine model of ovalbumin-induced allergic asthma via modulation of biochemical perturbations. Biomed Pharmacother
Visnagri A, Kandhare AD, Ghosh P, Bodhankar SL. Endothelin receptor blocker bosentan inhibits hypertensive cardiac fibrosis in pressure overload-induced cardiac hypertrophy in rats. Cardiovasc Endocrinol
Tambewagh UU, Kandhare AD, Honmore VS, Kadam PP, Khedkar VM, Bodhankar SL, et al. Anti-inflammatory and antioxidant potential of Guaianolide isolated from Cyathocline purpurea:
Role of COX-2 inhibition. Int Immunopharmacol
Sarkate AP, Murumkar PR, Lokwani DK, Kandhare AD, Bodhankar SL, Shinde DB, et al. Design of selective TACE inhibitors using molecular docking studies: Synthesis and preliminary evaluation of anti-inflammatory and TACE inhibitory activity. Sar Qsar Environ Res
Visnagri A, Kandhare AD, Chakravarty S, Ghosh P, Bodhankar SL. Hesperidin, a flavanoglycone attenuates experimental diabetic neuropathy via modulation of cellular and biochemical marker to improve nerve functions. Pharm Biol
Kandhare AD, Mukherjee AA, Bodhankar SL. Neuroprotective effect of Azadirachta indica
standardized extract in partial sciatic nerve injury in rats: Evidence from anti-inflammatory, antioxidant and anti-apoptotic studies. EXCLI J
Kandhare AD, Raygude KS, Kumar VS, Rajmane AR, Visnagri A, Ghule AE, et al. Ameliorative effects quercetin against impaired motor nerve function, inflammatory mediators and apoptosis in neonatal streptozotocin-induced diabetic neuropathy in rats. Biomed Aging Pathol
Adil M, Kandhare AD, Visnagri A, Bodhankar SL. Naringin ameliorates sodium arsenite-induced renal and hepatic toxicity in rats: Decisive role of KIM-1, Caspase-3, TGF- β, and TNF- α . Ren Fail
Devkar ST, Kandhare AD, Zanwar AA, Jagtap SD, Katyare SS, Bodhankar SL, et al. Hepatoprotective effect of withanolide-rich fraction in acetaminophen-intoxicated rat: Decisive role of TNF- α, IL-1 β, COX- II and iNOS. Pharm Biol
Kamble H, Kandhare AD, Bodhankar S, Mohan V, Thakurdesai P. Effect of low molecular weight galactomannans from fenugreek seeds on animal models of diabetes mellitus. Biomed Aging Pathol
Adil M, Kandhare AD, Ghosh P, Venkata S, Raygude KS, Bodhankar SL. Ameliorative effect of naringin in acetaminophen-induced hepatic and renal toxicity in laboratory rats: Role of FXR and KIM-1. Ren Fail
Badole SL, Chaudhari SM, Jangam GB, Kandhare AD, Bodhankar SL. Cardioprotective activity of Pongamia pinnata
in streptozotocin-nicotinamide induced diabetic rats. Biomed Res Int
Kandhare AD, Alam J, Patil MV, Sinha A, Bodhankar SL. Wound healing potential of naringin ointment formulation via regulating the expression of inflammatory, apoptotic and growth mediators in experimental rats. Pharm Biol
Aswar UM, Kandhare AD, Mohan V, Thakurdesai PA. Anti-allergic effect of intranasal administration of type-A procyanidin polyphenols based standardized extract of cinnamon bark in ovalbumin sensitized BALB/c mice. Phytother Res
Honmore V, Kandhare A, Zanwar AA, Rojatkar S, Bodhankar S, Natu A. Artemisia pallens
alleviates acetaminophen induced toxicity via modulation of endogenous biomarkers. Pharm Biol
Kandhare AD, Patil A, Guru A, Mukhrjee A, Sarkar S, Sengupta A, et al. Ameliorative effect of ferulic acid against acetic acid induced ulcerative colitis: Role of HO-1 and Nrf2. Pharmacologia
Ketkar S, Rathore A, Kandhare A, Lohidasan S, Bodhankar S, Paradkar A, et al. Alleviating exercise-induced muscular stress using neat and processed bee pollen: Oxidative markers, mitochondrial enzymes, and myostatin expression in rats. Integr Med Res
[Figure 1], [Figure 2]
[Table 1], [Table 2]
|This article has been cited by|
||A Pharmacological Perspective on Plant-derived Bioactive Molecules for Epilepsy
| ||Javad Sharifi-Rad,Cristina Quispe,Jesús Herrera-Bravo,Miquel Martorell,Farukh Sharopov,Tugba Boyunegmez Tumer,Begum Kurt,Chintha Lankatillake,Anca Oana Docea,Ana Catarina Moreira,Daniel A. Dias,Mohamad Fawzi Mahomoodally,Devina Lobine,Natália Cruz-Martins,Manoj Kumar,Daniela Calina |
| ||Neurochemical Research. 2021; |
|[Pubmed] | [DOI]|
||Neuroprotective role of Apocynin against Pentylenetetrazole kindling epilepsy and associated comorbidities in mice by suppression of ROS/RNS
| ||Gagandeep Jaiswal, Puneet Kumar |
| ||Behavioural Brain Research. 2021; : 113699 |
|[Pubmed] | [DOI]|
||Evaluation of the neuropharmacological effects of Gardenin A in mice
| ||Angel J. Alonso-Castro,Deisy Gasca-Martínez,Laura V. Cortez-Mendoza,Clara Alba-Betancourt,Alan J. Ruiz-Padilla,Juan R. Zapata-Morales |
| ||Drug Development Research. 2020; |
|[Pubmed] | [DOI]|
||Therapeutic Potential of Flavonoids as Alternative Medicines in Epilepsy
| ||Jae Young Kwon,Min-Tae Jeon,Un Ju Jung,Dong Woon Kim,Gyeong Joon Moon,Sang Ryong Kim |
| ||Advances in Nutrition. 2019; |
|[Pubmed] | [DOI]|
||Attenuation of reserpine-induced fibromyalgia via ROS and serotonergic pathway modulation by fisetin, a plant flavonoid polyphenol
| ||Xianli Yao,Li Li,Amit Kandhare,Anwesha Mukherjee-Kandhare,Subhash Bodhankar |
| ||Experimental and Therapeutic Medicine. 2019; |
|[Pubmed] | [DOI]|